Surgery · Indianapolis, IN
NPI
1730122268
Since 2006
Specialty
Surgery
Code 208600000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3850 Shore Dr, Ste 315
Indianapolis, IN, 46254
Phone (317) 429-0061
Groups this clinician bills Medicare through
Medicare paid, 2024
$223K
3,186 services
Medicare patients, 2024
424
Average age 57
Drug cost, 2024
$5.1M
26,160 prescriptions
Company payments, 2025
$4,960
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael S Miller was code 90837 (psychotherapy - nongroup), 775 times for 89 patients. In total Michael S Miller billed 3,186 services in 49 codes, and Medicare paid $223K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90837 Psychotherapy - Nongroup | Office | 775 | 89 | $100.75 | $78K |
| 99214 Office E&M - Established | Office | 741 | 243 | $65.29 | $48K |
| 99350 Home E&M - New and Established | Office | 272 | 92 | $108.48 | $30K |
| 99458 E&M - Miscellaneous | Office | 267 | 24 | $26.41 | $7,051 |
| 99457 E&M - Miscellaneous | Office | 186 | 27 | $31.16 | $5,796 |
| 99349 Home E&M - New and Established | Office | 173 | 66 | $83.93 | $15K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 126 | 14 | $31.57 | $3,978 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 112 | 17 | $40.96 | $4,588 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 61 | 40 | $89.87 | $5,482 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 60 | 31 | $10.95 | $657 |
| 90834 Psychotherapy - Nongroup | Office | 60 | 21 | $60.61 | $3,636 |
| 90791 Psychotherapy - Nongroup | Office | 55 | 53 | $104.54 | $5,750 |
| 99213 Office E&M - Established | Office | 50 | 32 | $53.83 | $2,692 |
| 99454 E&M - Miscellaneous | Office | 38 | 13 | $27.62 | $1,050 |
| 90792 Psychotherapy - Nongroup | Office | 28 | 28 | $83.29 | $2,332 |
By year: 2022 $90K for 1,255 services; 2023 $133K for 2,832 services; 2024 $223K for 3,186 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael S Miller prescribed most often to Medicare patients was Trazodone Hcl, with 757 prescriptions and refills. In total Michael S Miller wrote 26,160 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trazodone Hcl Generic | 757 | 784 | 92 | $13K |
| Risperidone Generic | 717 | 734 | 64 | $19K |
| Levothyroxine Sodium Generic | 712 | 733 | 68 | $10K |
| Sertraline Hcl Generic | 668 | 696 | 67 | $8,054 |
| Buspirone Hcl Generic | 666 | 699 | 88 | $14K |
| Clonazepam Generic | 542 | 551 | 56 | $6,890 |
| Benztropine Mesylate Generic | 510 | 521 | 57 | $9,143 |
| Divalproex Sodium Generic | 501 | 512 | 48 | $45K |
| Aripiprazole Generic | 476 | 506 | 60 | $65K |
| Olanzapine Generic | 466 | 478 | 52 | $26K |
| Quetiapine Fumarate Generic | 450 | 466 | 47 | $21K |
| Carvedilol Generic | 440 | 458 | 45 | $4,943 |
| Escitalopram Oxalate Generic | 430 | 458 | 54 | $7,302 |
| Metformin Hcl Generic | 382 | 389 | 45 | $4,322 |
| Atorvastatin Calcium Generic | 380 | 411 | 50 | $5,611 |
Brand drugs: 3,623 claims; generic drugs: 22,440 claims; opioid claims: 344.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael S Miller $4,960 ($4,960 in general payments such as food, travel and fees) from 26 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $940.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 49 | $940 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 31 | $569 |
| E.R. Squibb & Sons, L.L.C. BMY | 18 | $499 |
| Vanda Pharmaceuticals Inc. VNDA | 17 | $495 |
| Janssen Pharmaceuticals, Inc JNJ | 11 | $375 |
| Axsome Therapeutics, Inc. AXSM | 7 | $296 |
| Supernus Pharmaceuticals, Inc. SUPN | 12 | $265 |
| Jazz Pharmaceuticals Inc. JAZZ | 7 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $209 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $166 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.